ConductScience.org, home

Trial · NCT04306653

Registered outcomes25

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryPain VAS12 hoursIntensity of pain will be recorded using a Visual Analogue Scale (VAS) (0-10, 0=no pain 10=worst pain)
PrimaryPain VAS24 hoursIntensity of pain will be recorded using a Visual Analogue Scale (VAS) (0-10, 0=no pain 10=worst pain)
PrimaryPain VAS48 hoursIntensity of pain will be recorded using a Visual Analogue Scale (VAS) (0-10, 0=no pain 10=worst pain)
PrimaryPain VAS72 hoursIntensity of pain will be recorded using a Visual Analogue Scale (VAS) (0-10, 0=no pain 10=worst pain)
PrimaryPain VAS5 daysIntensity of pain will be recorded using a Visual Analogue Scale (VAS) (0-10, 0=no pain 10=worst pain)
SecondaryPhysician global assessment24 hoursPhysician global assessment rated on a Visual Analogue Scale (VAS) (0-100, 0=very good, 100=very bad)
SecondaryPhysician global assessment48 hoursPhysician global assessment rated on a Visual Analogue Scale (VAS) (0-100, 0=very good, 100=very bad)
SecondaryPhysician global assessment72 hoursPhysician global assessment rated on a Visual Analogue Scale (VAS) (0-100, 0=very good, 100=very bad)
SecondaryPhysician global assessment5 daysPhysician global assessment rated on a Visual Analogue Scale (VAS) (0-100, 0=very good, 100=very bad)
SecondaryPatient global assessment24 hoursPatient global assessment rated on a Visual Analogue Scale (VAS) (0-100, 0=very good, 100=very bad)
SecondaryPatient global assessment48 hoursPatient global assessment rated on a Visual Analogue Scale (VAS) (0-100, 0=very good, 100=very bad)
SecondaryPatient global assessment72 hoursPatient global assessment rated on a Visual Analogue Scale (VAS) (0-100, 0=very good, 100=very bad)
SecondaryPatient global assessment5 daysPatient global assessment rated on a Visual Analogue Scale (VAS) (0-100, 0=very good, 100=very bad)
SecondaryTenderness24 hoursTenderness rated using 0-3 scale (0=no tenderness, 3=severe tenderness)
SecondaryTenderness48 hoursTenderness rated using 0-3 scale (0=no tenderness, 3=severe tenderness)
SecondaryTenderness72 hoursTenderness rated using 0-3 scale (0=no tenderness, 3=severe tenderness)
SecondaryTenderness5 daysTenderness rated using 0-3 scale (0=no tenderness, 3=severe tenderness)
SecondarySwelling24 hoursSwelling rated using 0-3 scale (0=no swelling, 3=severe swelling)
SecondarySwelling48 hoursSwelling rated using 0-3 scale (0=no swelling, 3=severe swelling)
SecondarySwelling72 hoursSwelling rated using 0-3 scale (0=no swelling, 3=severe swelling)

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04306653/registered